Back to dashboard
All PlansAdministrativeMedium impact

Voluntary nationwide recall: Sulfamethoxazole/Trimethoprim (Amneal – June)

UPMC Health Plan·Family Medicine, Internal Medicine, General Practice +4 more·Pharmacy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

Amneal Pharmaceutical LLC is voluntarily recalling certain lots of Sulfamethoxazole/Trimethoprim tablets due to microbial contamination causing black spots. Healthcare providers should check if prescribed medications are affected and advise patients to stop using recalled lots immediately.

Action Required

Action needed
Immediately: Clinical staff should identify patients prescribed Sulfamethoxazole/Trimethoprim tablets (400mg/80mg) from Amneal and check lot numbers against FDA recall list. Contact affected patients to discontinue use and return medication. Document in patient charts and consider alternative antibiotic therapy. Billing team should be prepared for potential medication changes and new prescriptions.